SPECIFIC PHARMA A/S: Financial statements 2013
CVR: 33161395
Source: annual report 2013, Danish Business Authority
01/02/2012 – 31/01/2013
SPECIFIC PHARMA A/S (CVR 33161395) has filed annual accounts for 2013. In 2013, the company reported revenue of DKK 60,116,598 and a net result of DKK 10,587,627. The profit margin was 17.6%. Equity in the 2013 report amounted to DKK 18,586,454. The solvency ratio was 76%.
- Revenue
- DKK 60,116,598
- Gross Profit
- DKK 16,826,391
- Profit/Loss
- DKK 10,587,627
- Equity
- DKK 18,586,454
- Total Assets
- DKK 24,454,787
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationAbout SPECIFIC PHARMA A/S
SPECIFIC PHARMA A/S is a Danish company of the type Aktieselskab based in København SV, founded in 2010. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Uffe Kåre Jensen. The board consists of Kristine Sakstrup Haag (chair), Henrik Kaastrup, Kasper Casparij Yde and Ken Rasmussen. The company is owned by NOMECO A/S. The company has 24 employees (2018). In 2026, the company reported revenue of DKK 157,797,000 and a net result of DKK 15,192,000 compared with DKK 29,239,000 the year before. Equity in the 2026 report amounted to DKK 98,645,000.